NBC Securities’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.9K Hold
113
﹤0.01% 1579
2026
Q1
$22.1K Sell
113
-97
-46% -$18.8K ﹤0.01% 1674
2025
Q4
$36.4K Hold
210
﹤0.01% 1483
2025
Q3
$40K Sell
210
-16
-7% -$2.84K ﹤0.01% 1415
2025
Q2
$40K Buy
226
+16
+8% +$2.78K ﹤0.01% 1402
2025
Q1
$35K Buy
+210
New +$34.5K ﹤0.01% 1275
2024
Q4
Sell
-235
Closed -$36K 1455
2024
Q3
$36K Hold
235
﹤0.01% 1277
2024
Q2
$32K Buy
235
+25
+12% +$3.42K ﹤0.01% 1275
2024
Q1
$27K Hold
210
﹤0.01% 1343
2023
Q4
$28K Hold
210
﹤0.01% 1326
2023
Q3
$25K Buy
+210
New +$28K ﹤0.01% 1353

Other funds holding DGX

NBC Securities's DGX Position: Q2 2026 in Review

NBC Securities held its Quest Diagnostics (DGX) position steady in Q2 2026 at 113 shares worth $23.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1579.

NBC Securities first reported a position in DGX in Q3 2023 and has held it in 11 quarters since. The position peaked at $40K in Q3 2025. 1,105 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • NBC Securities held 113 shares of Quest Diagnostics worth $23.9K as of Q2 2026.
  • NBC Securities left its Quest Diagnostics share count unchanged in Q2 2026.
  • Quest Diagnostics made up ﹤0.01% of NBC Securities's portfolio in Q2 2026, its #1579 holding.
  • NBC Securities first reported a position in Quest Diagnostics in Q3 2023 and has held it in 11 quarters since.
  • NBC Securities's Quest Diagnostics position peaked at $40K in Q3 2025.
  • 1,105 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.